May 17, 2017 TOULOUSE, France–(BUSINESS WIRE)–Regulatory News: VEXIM (Paris:ALVXM) (FR0011072602 – ALVXM), a medical device company specializing in the minimally invasive treatment of vertebral fractures, today announces its fifth-year anniversary on the Alternext market. “After five years of quotation on the Alternext market, VEXIM has made tremendous progress on all […]

Share on LinkedInShare on FacebookShare on Google+Pin on PinterestEmail this to someone